-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II

Symposia: Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Hetanshi Naik, PhD1*, Manisha Balwani, MD2*, Hilary H Colwell, MPH3*, Susan D Mathias, MPH3*, Kristen Wheeden, MBA4*, Chelsea Norregaard, PhD, MPH5*, Melanie Chin, PhD5* and William Savage, MD, PhD5

1Stanford University, Palo Alto, CA
2Icahn School of Medicine At Mount Sinai, New York, NY
3Health Outcomes Solutions, Palm Beach Gardens, FL
4United Porphyrias Association, Bethesda, MD
5Disc Medicine, Watertown, MA

Kevin Chien1*, Lindsay Cowley, MA2*, Daniel Warner, BScH, CCRP2*, Derek Little, MD1*, Margaret Ostrowski3*, Carol West3*, Roy Khalife, MD, MHPE, FRCPC2,4 and Deborah Siegal, MD, MSc2,5

1Department of Medicine, McMaster University, Hamilton, ON, Canada
2Ottawa Hospital Research Institute, Ottawa, ON, Canada
3CanVECTOR, Montreal, QC, Canada
4Department of Medicine, University of Ottawa, The Ottawa Hospital, Ottawa, ON, Canada
5Department of Medicine, University of Ottawa, Ottawa, ON, Canada

Anna L. Parks, MD1, Rushad Patel, MBBS2, Dana Elizabeth Angelini, MD3, Jordan K Schaefer, MD, MSc4, Ang Li, MD, MS5, Alejandra Gutierrez Bernal, MD6*, Shruti Chaturvedi, MBBS7, Anjlee Mahajan, MD8, Leslie L Lake, BA9* and Jori E. May, MD10

1Department of Medicine, Division of Hematology & Hematologic Malignancies, University of Utah, Salt Lake City, UT
2BIDMC, Boston, MA
3Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
4Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
5Baylor College of Medicine, Houston, TX
6University of Minnesota, Minneapolis
7Division of Hematology, Department of Medicine, Johns Hopkins Hospital, BALTIMORE, MD
8University of California, Davis, Sacramento, CA
9National Blood Clot Alliance, New York, NY
10Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL

Roy Khalife, MD, MHPE, FRCPC1,2, Lindsay Cowley, MA1*, Alan T. Tinmouth, MD, MSc1,3*, Lisa D. Duffett, MD, MSc1,3*, Vanessa Bourck, RN, BScN, MN4*, Alfonso Iorio, MD, PhD5, Davide Matino, MD, MSc6*, Kay Decker, RN7*, Karen Strike, PhD, MScPT, BKinHons8*, David Page9*, Natasha Pardy, MD, FRCPC10*, Jerome M. Teitel, MD11 and Haowei Linda Sun, MD MHSc FRCPC12

1Ottawa Hospital Research Institute, Ottawa, ON, Canada
2Department of Medicine, University of Ottawa, The Ottawa Hospital, Ottawa, ON, Canada
3Department of Medicine, University of Ottawa, Ottawa, ON, Canada
4The Ottawa Hospital, Ottawa, ON, Canada
5Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
6Thrombosis and Atherosclerosis Research Institute (TaARI), McMaster University, Hamilton, ON, Canada
7McMaster Children's Hospital, Hamilton Health Sciences, Hamilton, ON, Canada
8Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
9Canadian Hemophilia Society, Montreal, QC, Canada
10Division of Hematology, Eastern Health, St. John's, NF, Canada
11Division of Hematology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
12Division of Hematology, Department of Medicine, University of Alberta, Edmonton, AB, Canada

Abdelrahman Noureldin, BHSc1*, Victoria Ivankovic, MD2*, Mary Farnand, RN/IA, BScN, MN2*, Celine Dainhi3*, Rebecca Auer, MD, MSc2*, Sameer Apte, MD2*, Lev Bubis, MD4*, Pamela Hebbard, MD3*, Justin Rivard, MD3*, Megan Delisle, MD3* and Marc Carrier, MD, MSc5

1Department of Medicine, University of Ottawa, Ottawa, Canada
2Department of Surgery, University of Ottawa, Ottawa, Canada
3Cancer Care Manitoba (CCMB), Winnipeg, Canada
4Department of Surgery, University of Manitoba, Winnipeg, Canada
5Department of Medicine, University of Ottawa at The Ottawa Hospital and the Ottawa Hospital Research Institute, Ottawa, Canada

Azra Borogovac, MD1, Ellie Moses-Okwei, PhD2*, Lindsay Gurska, PhD2*, Emily Zyborowicz, MPH2*, Shelby Sullivan, PharmD2*, Jeffrey Carter, PhD2* and Cherilyn Heggen, PhD2*

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2PRIME Education, New York, NY

Prakhyath Srikaram, Paul S Levy, MD, MBA* and Charlotte Brewer*

Baptist Memorial Hospital - North Mississippi, Oxford, MS

Swetha Kambhampati Thiruvengadam, MD1, Nikhil Thiruvengadam2*, Steven T. Rosen, MD3, Chadi Nabhan, MD, MBA4, Kevin Knopf, MD MBA5*, Linda Martin, PhD6*, Kenneth R. Carson, MD, PhD7, Peter Georgantopoulos8*, Gretchen Watson6*, Edward Smith9*, Edward Zyszkowski10*, Sony Jacob11*, Dennis Banegas, BA12*, William Hrushesky, MD6*, Iain Cumming Macdougall, BSc, MBBChir, MD, MRCP, FRCP13*, Manuel Gonzalez-Brio14*, David Aboulafia, MD15*, Oliver Sartor16*, Robert Peter Gale17* and Charles Bennett, MD11

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Gastroenterology, Loma Linda University, Loma Linda, CA
3Department of Hematology and HCT, City of Hope Comprehensive Cancer Center, Duarte, CA
4University of South Carolina, Deerfield, IL
5U of SOuth Carolina, COLUMBIA, SC
6U of South Carolina, Columbia
7Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago
8U of South Carolina, Columbia, SC
9University of South Carolina, Columbia, CA
10University of South Carolina, Columbia
11University of South Carolina, Columbia, SC
12Smart State Center for Medication Safety and Efficacy, University of South Carolina, COLUMBIA, SC
13King's College Hospital, London, GBR
14University of Miami, Miami, FL
15Virginia Mason Clinic, Seattle
16Mayo Clinic, Rochester, MN
17Centre For Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, GBR

Jennifer Heimall1,2*, Luis Ignacio González Granado3,4*, Claire Booth, MBBS, PhD5*, Patrice Carter6*, Emily Matthews6*, Maria Chitty-Lopez, MD7*, Miranda Bailey7*, Susan E Prockop, MD8*, Andrew R Gennery, MD9* and Jennifer W Leiding, MD10,11,12*

1Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3Department of Pediatrics, Immunodeficiency Unit, University Hospital 12 de Octubre, Madrid, Spain
4School of Medicine, Complutense University, Madrid, Spain
5Department of Paediatric Immunology and Gene Therapy, Great Ormond Street Hospital NHS Trust, London, United Kingdom
6Health Economics and Outcomes Research Ltd., Cardiff, United Kingdom
7Rocket Pharmaceuticals, Inc., Cranbury, NJ
8Stem Cell Transplant Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
9Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom
10Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD
11Cancer and Blood Disorders Institute, Johns Hopkins All Children’s Hospital, St. Petersburg, FL
12Institute for Clinical and Translational Research, John Hopkins All Children's Hospital, St. Petersburg, FL

Josette M Kamel, MD1 and Mark Chaitowitz, MD2

1Internal Medicine, Montefiore Medical Center, The Bronx, NY
2Hematology, Montefiore Medical Center, New York, NY

Ang Li, MD, MS1, Shengling Ma, MD, PhD2, Raka Bandyo, MS3*, Mrinal Ranjan, MPH1*, Elizabeth Chiang4*, Joyce Tiong1*, Jun Yang Jiang, MD1, Justine Ryu, MD5, Omid Jafari, PhD1*, Christopher I Amos1*, Nathanael R. Fillmore, PhD6*, Jennifer La6*, Karlyn A. Martin, MD, MS7, Chirayu J Shah, MD1* and Aparna Jotwani, MD1*

1Baylor College of Medicine, Houston, TX
2Section of Hematology-Oncology, Baylor College of Medicine, HOUSTON, TX
3Harris Health System, Houston, TX
4Baylor College of Medicine, houston, TX
5Section of Hematology, Yale University School of Medicine, New Haven, CT
6VA Boston Healthcare System, Boston, MA
7Division of Hematology and Oncology, University of Vermont Larner College of Medicine, Burlington, VT

Julia Levy, MD1*, Rabeka Ali, MS2*, Mandy VanSandt, DO2*, Shelby Koppinger, Pharm D3*, Francisco Hernandez-Ilizaliturri, MD4* and Merav Sendowski, MD5

1Department of Internal Medicine, Oregon Health and Science University, Oregon Health and Science University, Portland, OR
2Department of Pathology and Laboratory Medicine, Oregon Health and Science University, Portland, OR
3Department of Pharmacy, Oregon Health & Science University, Oregon Health and Science University, Portland, OR
4Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
5Department of Hematology and Oncology, Oregon Health and Science University, Oregon Health and Science University, Portland, OR

Charles Greenberg, MD1, Kimberley Youkhana, MD, MSCR2 and Benjamin Djulbegovic, MD PhD1

1Medical University of South Carolina, Charleston, SC
2Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC

Kunal C Potnis, MD1*, Satoko Ito, MD, PhD2, Kishan Patel, MD3*, Rory M. Shallis, MD4,5, Nikolai A. Podoltsev, MD, PhD2,6, Tariq Kewan, MD7, Jessica M. Stempel, MD7, Lourdes Mendez, MD8*, Scott F Huntington9,10, Maximilian Stahl, MD11, Amer M. Zeidan, MBBS, MHS5,8, Jan Philipp Bewersdorf, MD5,8 and George Goshua, MD, MSc12,13

1Department of Internal Medicine, Yale School of Medicine, New Haven, CT
2Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
3Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA, New York, NY
4Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, Killingworth, CT
5Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT
6Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, New Haven, CT
7Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
8Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
9Yale School of Medicine, New Haven, CT
10Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT
11Dana Farber Cancer Institute, Boston, MA
12Hematology-Oncology & Yale CORE, Yale School of Medicine & Yale Cancer Center, New Haven, CT
13Center for Outcomes Research and Evaluation, Yale University and Yale New Haven Hospital, New Haven, CT

*signifies non-member of ASH